Prima Medical Limited Filleted accounts for Companies House (small and micro)
Prima Medical Limited Filleted accounts for Companies House (small and micro)
COMPANY REGISTRATION NUMBER:
04831749
|
|
|
|
Abridged Financial Statements |
Year ended 31 July 2021
Contents |
Page |
Chartered accountants report to the board of directors on the preparation of the unaudited statutory abridged financial statements |
1 |
Abridged statement of financial position |
2 |
Notes to the abridged financial statements |
4 |
|
Chartered Accountants Report to the Board of Directors on the Preparation of the Unaudited Statutory Abridged Financial Statements of
|
Year ended 31 July 2021
Midway House
Staverton Technology Park
Herrick Way, Staverton
Cheltenham, Glos.
GL51 6TQ
|
Abridged Statement of Financial Position |
2021 |
2020 |
|
Note |
£ |
£ |
Fixed assets
Intangible assets |
5 |
|
|
Tangible assets |
6 |
|
|
--------- |
-------- |
||
|
|
||
Current assets
Stocks |
|
|
Debtors |
|
|
Cash at bank and in hand |
|
|
--------- |
--------- |
|
|
|
|
Creditors: amounts falling due within one year |
|
|
--------- |
--------- |
|
Net current liabilities |
|
|
--------- |
-------- |
|
Total assets less current liabilities |
|
|
Creditors: amounts falling due after more than one year |
|
|
--------- |
--------- |
|
Net liabilities |
(
|
(
|
--------- |
--------- |
|
Capital and reserves
Called up share capital |
|
|
Share premium account |
|
|
Profit and loss account |
(
|
(
|
--------- |
--------- |
|
Shareholders deficit |
(
|
(
|
--------- |
--------- |
|
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements
.
|
Abridged Statement of Financial Position (continued) |
These abridged financial statements were approved by the
board of directors
and authorised for issue on
27 July 2022
, and are signed on behalf of the board by:
|
Director |
Company registration number:
04831749
|
Notes to the Abridged Financial Statements |
Year ended 31 July 2021
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Midway House, Herrick Way, Staverton Technology Park, Staverton, Cheltenham, GL51 6TQ.
2.
Statement of compliance
3.
Accounting policies
Basis of preparation
Revenue recognition
Income tax
Foreign currencies
Intangible assets
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Development costs |
- |
|
|
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Research and development
Tangible assets
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Motor vehicles |
- |
|
|
Office equipment |
- |
|
|
Impairment of fixed assets
Stocks
Government grants
Defined contribution plans
4.
Employee numbers
The average number of persons employed by the company during the year amounted to
4
(2020:
3
).
5.
Intangible assets
£ |
|
Cost |
|
At 1 August 2020 |
|
Additions |
|
--------- |
|
At 31 July 2021 |
|
--------- |
|
Amortisation |
|
At 1 August 2020 |
|
Charge for the year |
|
--------- |
|
At 31 July 2021 |
|
--------- |
|
Carrying amount |
|
At 31 July 2021 |
|
--------- |
|
At 31 July 2020 |
|
--------- |
|
6.
Tangible assets
£ |
|
Cost |
|
At 1 August 2020 |
|
Additions |
|
-------- |
|
At 31 July 2021 |
|
-------- |
|
Depreciation |
|
At 1 August 2020 |
|
Charge for the year |
|
-------- |
|
At 31 July 2021 |
|
-------- |
|
Carrying amount |
|
At 31 July 2021 |
2,979 |
-------- |
|
At 31 July 2020 |
2,128 |
-------- |
|
7.
Events during the year
During 2020 the company benefited from diversifying into the PPE market in order to maintain sales revenue and profitability. However, as the pandemic relinquished the company returned its focus to the ongoing development of its new product lines. Therefore whilst overall sales fell there was a large increase in the sale of new surgical products and this has continued into 2022. This is despite a backdrop of challenges in the supply chain across the globe. The company is confident that it will maintain steady growth over the coming years and already has new products under development.
8.
Directors' advances, credits and guarantees
9.
Related party transactions
10.